Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083Hannah P. Moore, Susan H. Eshleman, Mark A. Marzinke et al.|Open Forum Infectious Diseases|2025Cited by 0